Pingyong Yi
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis.
Journal: Frontiers in endocrinology
Published: July 16, 2022
Inhibitory effect of PI3Kδ inhibitor idelalisib on proliferation of human myeloid leukemia cells and the reversal effect on drug resistance to adriamycin.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: January 21, 2021
Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2+ Breast Cancer Cells to 5-Fluorouracil.
Journal: Oncology research
Published: July 31, 2020
A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma.
A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma.
Journal: Frontiers in endocrinology
Published: May 09, 2020
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma.
Journal: Journal of hematology & oncology
Published: February 11, 2020
Clinicopathological Features, Treatment, and Prognosis in Primary Diffuse Large B Cell Lymphoma of the Breast: A Retrospective Study of 46 Patients.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 18, 2019
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group.
Journal: Leukemia
Published: August 19, 2019
Short-Course Versus Long-Course Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: May 02, 2018
Retraction notice to "BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma" [Biochem. Biophys. Res. Commun. 491 (2017) 939-945].
Journal: Biochemical and biophysical research communications
Published: March 14, 2018
A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Journal: Journal of Cancer
Published: December 12, 2017
BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma.
Journal: Biochemical and biophysical research communications
Published: July 19, 2017
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.
Journal: Journal of hematology & oncology
Published: January 16, 2017
Last Updated: 09/26/2026